FDA Inspection 1297680 — Shandong Jincheng Kunlun Pharmaceutical Co., Ltd.
The FDA completed an inspection of Shandong Jincheng Kunlun Pharmaceutical Co., Ltd. on December 5, 2025 in Zibo. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- December 5, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Zibo (China)